The industrial hub faces a massive shortfall in revenues amid growing cost of combating the pandemic

Of the 1,089 new cases, Mumbai accounted for 748, with a cumulative tally of 12,142. With 75 new cases, Pune district’s tally has risen to 2,537.

Bhopal, by comparison, has so far reported 679 cases and 24 deaths, with 354 patients, or more than half of those infected, having recovered.

Two prominent medical experts — AIIMS director Dr Randeep Guleriya and Dr. Manish Suneja — flew into Ahmedabad on Friday following instructions from the Home Minister to guide local doctors

Major chunk of cases reported from Gurdaspur, Tarn Taran districts

43 cases from Ganjam district; State’s total mounts to 271

"We don’t want anything from the government. We just want to be dropped home," says a migrant worker from Chhattisgarh.

Bandipora tops the list with 134 cases, followed by Srinagar at 129

This has been the highest spike in the number of cases in the State in a single day, taking the number of cases to 1,678

Rupa Rani Bhuyan, assistant professor of Mangaldoi College, was held for “misbehaving” with the police and “obstructing” them from investigating cases against her

State health officials are planning extensive tests

Interview with Nehal N. Mehta, MD, MSCE, author of Association Between Aortic Vascular Inflammation and Coronary Artery Plaque Characteristics in Psoriasis, and Jagat Narula, MD, PhD, author of Inflammation, Superadded Inflammation, and Out-of-Proportion Inflammation in Atherosclerosis

Interview with Robert W. Yeh, MD, MSc, MBA, author of Temporal Trends in Unstable Angina Diagnosis Codes for Outpatient Percutaneous Coronary Interventions, and David L. Brown, MD, FACC, author of Gaming, Upcoding, Fraud, and the Stubborn Persistence of Unstable Angina

Interview with Benjamin D. Levine, author of Association of All-Cause and Cardiovascular Mortality With High Levels of Physical Activity and Concurrent Coronary Artery Calcification

Interview with Barry H. Greenberg, author of Association of Rivaroxaban With Thromboembolic Events in Patients With Heart Failure, Coronary Disease, and Sinus Rhythm: A Post Hoc Analysis of the COMMANDER HF Trial, and Marvin A. Konstam, MD, author of Antithrombotic Therapy in Heart Failure—The Clot Thickens

Interview with Stephen W. Waldo, MD, author of Association of Coronary Anatomical Complexity With Clinical Outcomes After Percutaneous or Surgical Revascularization in the Veterans Affairs Clinical Assessment Reporting and Tracking Program

Interview with Robert O. Bonow, MD, Patrick T. O'Gara, MD, Clyde W. Yancy, MD, and Gregg C. Fonarow, MD, authors of Association of Coronavirus Disease 2019 (COVID-19) With Myocardial Injury and Mortality and Ajay J. Kirtane, MD

In March, Dybala confirmed he and his girlfriend, Oriana Sabatini, tested positive for coronavirus.

Experts stress the need for an over-arching central law to deal with epidemics

The industry's reliance on China-based firms for chemistry services is in the spotlight

Cryo-EM structure of key coronavirus protein could help develop vaccines against the virus

Medical workers in China weigh the advantages and disadvantages of nucleic acid lab tests and CT lung scans

Facilities are reopening in China but spread of virus outside China is raising concerns

Gilead has a head start on an antiviral, while Moderna is pursuing a novel mRNA vaccine

Industry watchers say the effort is unprecedented and would not have been possible during the last SARS outbreak

The tests can still be used, CDC says, as urgency over possible outbreak grows

Petrochemical and pharma meeting organizers say travel was becoming too difficult; ACS spring meeting is still on

Product launches and champagne toasts at instrumentation conference bely worries about infection

Early batches of the test can still be used, CDC says, while affirming it will deploy new kits

Congress opts for open-ended support for federal and local agencies

The structure shows the first steps of SARS-CoV-2 infection, and could help in drug discovery

Petrochemical and pharma meeting organizers say travel was becoming too difficult; ACS spring meeting is still on

Gilead has a head start on an antiviral, while Moderna is pursuing a novel mRNA vaccine

Product launches and champagne toasts belied worries about infection

Gilead toma ventaja gracias a un antiviral, mientras que Moderna está buscando una nueva vacuna ARNm.

C&EN looks at how scientists are adapting to travel restrictions and working from home

Spring lineup of conferences and events frequented by chemists is slashed

Hear what C&EN's pharmaceutical editors have learned about how the coronavirus is affecting drug production in China and across the globe

Chemical makers brace for a slowdown on the continent

Several approved and well-studied small molecules could be repurposed as treatments for COVID-19

The novel virus is one of the easiest virus types to deactivate, though SARS-CoV-2–specific data are lacking

Congress opts for open-ended support for federal and local agencies

C&EN looks at how scientists are working from home and adapting to travel restrictions

The structure shows the first steps of SARS-CoV-2 infection and could help in drug discovery

Specialty chemical CEOs are rolling with the punches to keep their firms going

Chemical makers and oil producers are pulling back on production, reconsidering investments